NEW YORK, Feb. 29, 2024 Progyny, Inc. , a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share.
Progyny (NASDAQ:PGNY – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.540-1.590 for the period, compared to the consensus EPS estimate of 0.700. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion. Progyny […]
Progyny, Inc. Announces Share Repurchase Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, . .
Progyny (NASDAQ:PGNY – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Cantor Fitzgerald in a research note issued on Wednesday, Benzinga reports. They currently have a $48.00 price target on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 44.53% from the stock’s current price. A number of […]